TEVA PHARMACEUTICAL INDUSTRIES LIMITED Assets, Fair Value Adjustment
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Assets, Fair Value Adjustment of -$300.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
us-gaap:AssetsFairValueAdjustment · last filed 2026-07-29
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED assets, fair value adjustment for the quarter ending 2026-06-30 was -$300.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED assets, fair value adjustment for the quarter ending 2026-03-31 was -$283.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED assets, fair value adjustment for the quarter ending 2025-12-31 was -$3.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED assets, fair value adjustment for the quarter ending 2025-09-30 was $4.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED assets, fair value adjustment for fiscal 2024 was -$684.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED assets, fair value adjustment for fiscal 2023 was $0.00.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED assets, fair value adjustment for fiscal 2022 was -$10.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED assets, fair value adjustment for fiscal 2021 was -$76.00M.
| Period end | Assets, Fair Value Adjustment 3 month | Assets, Fair Value Adjustment 6 month | Assets, Fair Value Adjustment 9 month | Assets, Fair Value Adjustment 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$300.00M 10-Q · filed 2026-07-29 | -$583.00M derived: sum of 2 quarters · filed 2026-07-29 | -$586.00M derived: sum of 3 quarters · filed 2026-07-29 | -$582.00M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | -$283.00M 10-Q · filed 2026-04-29 | -$286.00M derived: sum of 2 quarters · filed 2026-07-29 | -$282.00M derived: sum of 3 quarters · filed 2026-07-29 | -$338.00M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | -$3.00M derived: 10-Q 12 month − 10-Q 9 month · filed 2026-07-29 | $1.00M derived: sum of 2 quarters · filed 2026-07-29 | -$55.00M derived: sum of 3 quarters · filed 2026-07-29 | -$283.00M 10-Q · filed 2026-07-29 |
| 2025-09-30 | $4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$52.00M derived: sum of 2 quarters · filed 2025-11-05 | -$280.00M 10-Q · filed 2025-11-05 | -$509.00M derived: sum of 4 quarters · filed 2026-02-03 |
| 2025-06-30 | -$56.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | -$284.00M 10-Q · filed 2025-07-30 | -$513.00M derived: sum of 3 quarters · filed 2026-02-03 | -$563.00M derived: sum of 4 quarters · filed 2026-02-03 |
| 2025-03-31 | -$228.00M 10-Q · filed 2025-05-07 | -$457.00M derived: sum of 2 quarters · filed 2026-02-03 | -$507.00M derived: sum of 3 quarters · filed 2026-02-03 | -$448.00M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-12-31 | -$229.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | -$279.00M derived: sum of 2 quarters · filed 2026-02-03 | -$220.00M derived: sum of 3 quarters · filed 2026-02-03 | -$684.00M 10-K · filed 2026-02-03 |
| 2024-09-30 | -$50.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $9.00M derived: sum of 2 quarters · filed 2024-11-06 | -$455.00M 10-Q · filed 2024-11-06 | -$455.00M derived: sum of 4 quarters · filed 2025-02-05 |
| 2024-06-30 | $59.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | -$405.00M 10-Q · filed 2024-07-31 | -$405.00M derived: sum of 3 quarters · filed 2025-02-05 | -$397.00M derived: sum of 4 quarters · filed 2025-02-05 |
| 2024-03-31 | -$464.00M 10-Q · filed 2024-05-08 | -$464.00M derived: sum of 2 quarters · filed 2025-02-05 | -$456.00M derived: sum of 3 quarters · filed 2025-02-05 | -$454.00M derived: sum of 4 quarters · filed 2025-02-05 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-05 | $8.00M derived: sum of 2 quarters · filed 2025-02-05 | $10.00M derived: sum of 3 quarters · filed 2025-02-05 | $0.00 10-K · filed 2025-02-05 |
| 2023-09-30 | $8.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $10.00M derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | $20.00M derived: sum of 4 quarters · filed 2024-02-12 |
| 2023-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$8.00M 10-Q · filed 2023-08-02 | $12.00M derived: sum of 3 quarters · filed 2024-02-12 | $12.00M derived: sum of 4 quarters · filed 2024-02-12 |
| 2023-03-31 | -$10.00M 10-Q · filed 2023-05-10 | $10.00M derived: sum of 2 quarters · filed 2024-02-12 | $10.00M derived: sum of 3 quarters · filed 2024-02-12 | $31.00M derived: sum of 4 quarters · filed 2024-02-12 |
| 2022-12-31 | $20.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-12 | $20.00M derived: sum of 2 quarters · filed 2024-02-12 | $41.00M derived: sum of 3 quarters · filed 2024-02-12 | -$10.00M 10-K · filed 2024-02-12 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $21.00M derived: sum of 2 quarters · filed 2022-11-03 | -$30.00M 10-Q · filed 2022-11-03 | -$79.00M derived: sum of 4 quarters · filed 2023-02-10 |
| 2022-06-30 | $21.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | -$30.00M 10-Q · filed 2022-07-27 | -$79.00M derived: sum of 3 quarters · filed 2023-02-10 | -$64.00M derived: sum of 4 quarters · filed 2023-02-10 |
| 2022-03-31 | -$51.00M 10-Q · filed 2022-05-03 | -$100.00M derived: sum of 2 quarters · filed 2023-02-10 | -$85.00M derived: sum of 3 quarters · filed 2023-02-10 | -$113.00M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-12-31 | -$49.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | -$34.00M derived: sum of 2 quarters · filed 2023-02-10 | -$62.00M derived: sum of 3 quarters · filed 2023-02-10 | -$76.00M 10-K · filed 2023-02-10 |
| 2021-09-30 | $15.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | -$13.00M derived: sum of 2 quarters · filed 2021-10-27 | -$27.00M 10-Q · filed 2021-10-27 | -$10.00M derived: sum of 4 quarters · filed 2022-02-09 |
| 2021-06-30 | -$28.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | -$42.00M 10-Q · filed 2021-07-28 | -$25.00M derived: sum of 3 quarters · filed 2022-02-09 | -$66.00M derived: sum of 4 quarters · filed 2022-02-09 |
| 2021-03-31 | -$14.00M 10-Q · filed 2021-04-28 | $3.00M derived: sum of 2 quarters · filed 2022-02-09 | -$38.00M derived: sum of 3 quarters · filed 2022-02-09 | |
| 2020-12-31 | $17.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | -$24.00M derived: sum of 2 quarters · filed 2022-02-09 | -$296.00M 10-K · filed 2022-02-09 | |
| 2020-09-30 | -$41.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$313.00M 10-Q · filed 2020-11-05 | ||
| 2020-06-30 | -$272.00M 10-Q · filed 2020-08-05 | |||
| 2019-12-31 | -$11.00M 10-K · filed 2021-02-10 |